Titan Pharmaceuticals
TTNP
S$5.18
Share price
-8.22%
Change (1 day)
-32.33%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$0.35 Million
According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.35 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | S$1.9 M | -47.21% |
| 2022-12-31 | S$3.61 M | -6.43% |
| 2021-12-31 | S$3.86 M | -35.93% |
| 2020-12-31 | S$6.02 M | -44.74% |
| 2019-12-31 | S$10.9 M | 9.89% |
| 2018-12-31 | S$9.92 M | -7.81% |
| 2017-12-31 | S$10.76 M | 35.82% |
| 2016-12-31 | S$7.92 M | -11.02% |
| 2015-12-31 | S$8.9 M | -44.93% |
| 2014-12-31 | S$16.17 M | 0.81% |
| 2013-12-31 | S$16.04 M | -72.64% |
| 2012-12-31 | S$58.64 M | 49.47% |
| 2011-12-31 | S$39.23 M | 181.9% |
| 2010-12-31 | S$13.91 M | 152.07% |
| 2009-12-31 | S$5.52 M | |
| 2007-12-31 | S$6.12 M | 17.68% |
| 2006-12-31 | S$5.2 M | -0.33% |
| 2005-12-31 | S$5.22 M | -12.84% |
| 2004-12-31 | S$5.99 M | 5.53% |
| 2003-12-31 | S$5.67 M | -17.07% |
| 2002-12-31 | S$6.84 M | -35.85% |
| 2001-12-31 | S$10.67 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Vanda Pharmaceuticals VNDA | S$0.15 B | 43,096.77% | 🇺🇸 USA |
 MediciNova MNOV | S$3.21 M | 796.30% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | S$46.98 M | 12,978.85% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$148.79 B | 41,419,971.68% | 🇺🇸 USA |
 Novartis NVS | S$79.17 B | 22,038,968.10% | 🇨🇭 Switzerland |
 Repligen
RGEN | S$1.11 B | 310,530.82% | 🇺🇸 USA |